EIGENE PUBLIKATIONEN

Scherl M*, Posch U*, Obermoser G, Ammann C, Sepp N, Ulmer H, Dierich MP, Stoiber H, Falkensammer B.

* MS and UP contributed equally to the work

Targeting human immunodeficiency virus type 1 with antibodies derived from patients with connective tissue disease.

Lupus. 2006;15:865-872.

Online lesen

Mueller T, Posch UC, Lindner HH.

Separation of phenylthiohydantoin amino acids by capillary electrochromatography. Electrophoresis.

2004 Feb;25:578-585.

Online lesen

BEISPIELE FÜR MANUSKRIPTERSTELLUNG / EDITORIALE UNTERSTÜTZUNG

Kähler C., Derezinski T., Bocian-Sobkowska J., Keckeis A., Zacke G.

Spicae aetheroleum in uncomplicated acute bronchitis: a double-blind, randomised clinical trial.

Wien Med Wochenschr (2017). https://doi.org/10.1007/s10354-017-0612-0

Online lesen (Siehe „Acknowledgement section“)

Trimmel H., Majdan M., Wodak A., Herzer G., Csomor D., Brazinova A.

Citicoline in severe traumatic brain injury: indications for improved outcome : A retrospective matched pair analysis from 14 Austrian trauma centers.

Wien Klin Wochenschr. 2017 Jul 27. doi: 10.1007/s00508-017-1240-9. (epub ahead of print)

Online lesen (Siehe „Acknowledgement section“)

Willenbacher E., Willenbacher W., Gunsilius E.

Sustained response to single agent therapy with continuous lenalidomide in a pre-treated high-risk multiple myeloma patient.

Memo – Magazine of European Medical Oncology 2012; 5:27-29.

Online lesen (Siehe „Acknowledgement section“)

Skrabs C, Sillaber C, Schiefer AI, Simonitsch-Klupp I, Staudinger T, Putman M, Rabitsch W, Jaeger U

Lenalidomide induced response in a patient with follicular lymphoma of the skin and an anti-rituximab-antibody.

Memo – Magazine of European Medical Oncology 2013;6:123-126.

Online lesen (Siehe „Acknowledgement section“)

BEISPIELE FÜR POSTER

Gapp Guenther,

Practical Applications and Benefits of Sterile Product Compliance Risk Assessments and Case Studies.

2017 PDA Annual Meeting, April 3-5, Anaheim, CA

günther gapp pda poster 2017 Klick um PDF des Posters zu laden

Gapp Guenther,

Aseptic processing hot top from the view of a senior QA microbiologist and practical experiences in usage of sterile risk assessment tools.

2015 PDA Annual Meeting, March 16-18, Las Vegas, Nevada

guenther gapp ulrike posch Klick um PDF des Posters zu laden

ICH VERFÜGE ÜBER ERFAHRUNG IN FOLGENDEN FACHBEREICHEN

  • Akute Bronchitis
  • Antikörper-vermittelte (Chemo-)Therapien
  • EHEC (Enterohämorrhagische E.coli)
  • ESBL (Extended-spectrum-beta-lactamase-Bildner)
  • Hämatologie
    • Akute myeloische Leukämie (AML)
    • Follikuläres Lymphom (FL)
    • Multiples Myelom (MM)
    • Myelodysplastisches Syndrom (MDS)
  • HIV
  • Immunthrombozytopenie (ITP)
  • Immunmodulierende Therapien (IMIDs)
  • Immunonkologie (Talimogene Laherparepvec (T-VEC), BiTE antibody)
  • Nephrologie
  • Notfallkontrazeption
  • Onkologie
    • Breast cancer (mBC)
    • Colorectal cancer (mCRC)
    • Non-small cell lung cancer (NSCLC)
    • Pancreatic cancer (PDAC)
  • Osteoporose
  • Schädel-Hirn Trauma (SHT)
  • Sekundärer Hyperparathyreoidismus (SHPT)
  • Sterilproduktion in der pharmazeutischen Industrie
  • Systemischer Lupus erythematosus (SLE)